About the VHIR
Here at the Vall d'Hebron Research Institute (VHIR) we promote biomedical research, innovation and teaching. Over 1,800 people are seeking to understand diseases today so the treatment can be improved tomorrow.
Research
We are working to understand diseases, to find out how they operate and to create better treatments for patients. Get to know about our groups and their lines of research.
People
People are the centre of the Vall d'Hebron Research Institute (VHIR). This is why we are bound by the principles of freedom of research, gender equality and professional attitudes that HRS4R promotes.
Clinical trials
Our work is not just basic or translational; we are leaders in clinical research. Enter and find about the clinical trials we are conducting and why we are a world reference in this field.
Progress
Our aim is to make the research carried out at the Vall d’Hebron Research Institute (VHIR) a driving force for transformation. How? By identifying new channels and solutions for the promotion of people's health and well-being.
Core facilities
We offer specialist support for researchers, internal and external alike, ranging from specific services to preparing complete projects. All this, from a perspective of quality and speed of response.
News
We offer you a gateway for staying up to date on everything going on at the Vall d’Hebron Research Institute (VHIR), from the latest news to future solidarity activities and initiatives that we are organising.
Speaker: Dr. Mate Maus, group leader of the Aging and Cancer lab at the VHIO
Aging promotes the permissiveness of tissues to cancer, contributing thereby to the rising incidence of malignancies with aging. Chronic inflammation, fibrogenesis, and accumulation of senescent cells have all been proposed to drive the permissiveness of aged tissues to cancer. In young individuals, fibrogenesis, senescence and inflammation are part of a normal protective response to tissue injury that become exacerbated with aging. Senescent cells are a main driver of fibrogenesis through their inflammatory secretome, known as senescence-associated secretory phenotype (SASP). The mechanisms involved in fibrogenesis and in the conversion of damaged cells into senescent cells remain incompletely understood. We have recently shown that conversion of healthy tissues into fibrotic tissues and conversion of damaged cells into senescent cells are both associated with abnormal accumulation of iron. We found that iron accumulation was not just a bystander phenomenon, but a direct driver of fibrogenesis, inflammation, senescence and the SASP. We demonstrated that detection of iron by magnetic resonance imaging (MRI) is a powerful non-invasive method to assess and locate fibrotic burden. All tissues accumulate iron with aging. Our lab is currently exploring the connection between age-associated iron accumulation and the rising cancer incidence with age.
Host: Dr. Miguel Segura, Childhood Cancer and Blood Disorders group (VHIR)